97,8 %Of 1691 key populations living with HIV who had a viral load test, 97.8% (n = 1654) were virally suppressed (viral load ≤1000 copies/mL).
NigeriaVIH/sidapublié 2021PloS onePubMeddocument de 7 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 29 / 70
97,8 %Of 1691 key populations living with HIV who had a viral load test, 97.8% (n = 1654) were virally suppressed (viral load ≤1000 copies/mL).
NigeriaVIH/sidapublié 2021PloS onePubMeddocument de 7 observations
84 %The discontinuation rate of PrEP was 84% among HIV-negative individuals who initiated PrEP in two large-scale HIV programs in Akwa Ibom and Cross River states in Nigeria between January 2020 and July 2021.
NigeriaVIH/sidaobservé January 2020 to July 2021publié 2024BMC public healthPubMeddocument de 2 observations
41,8 %Only 41.8% of male senior secondary school students in Lagos, Nigeria knew where HIV Testing Services were offered.
NigeriaVIH/sidapublié 2019West African journal of medicinePubMeddocument de 7 observations
5 103 casesAmong 204,930 participants aged ≥18 months in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018, 5,103 were reactive on test 1 (Determine HIV-1/2).
NigeriaVIH/sidaobservé 2018publié 2022PLOS global public healtheurope_pmcdocument de 10 observations
5,7 %Stigma was cited as a reason for antiretroviral therapy non-adherence in 24 cases (5.7%) among female sex workers who died from HIV/AIDS.
NigeriaVIH/sidaobservé 2022-02-01 to 2023-02-28publié 2026International journal of environmental research and public healthPubMeddocument de 10 observations
19,1 %The prevalence of tuberculosis (TB) and human immunodeficiency virus (HIV) coinfection in Nigeria is currently around 19.1%.
Nigeriatuberculose · VIH/sidapublié 2022Microbiology spectrumPubMeddocument de 6 observations
96,2 %Viral suppression improved from 73.5% to 96.2% between the pre-surge and post-surge periods in Akwa Ibom State, Nigeria.
NigeriaVIH/sidapublié 2022PloS onePubMeddocument de 7 observations
HIV-1 subtype analysis revealed the predominance of CRF02_AG and subtype G in the study population.
NigeriaCRF02_AG · subtype G · VIH/sidapublié 2022AIDS (London, England)PubMeddocument de 4 observations
70 %Among 57 HIV-infected, HIV-exposed infants in Plateau State, Nigeria, 70% (40/57) had favorable treatment outcomes.
NigeriaVIH/sidaobservé 2018–2022publié 2026PloS onePubMeddocument de 13 observations
54 %Among people living with HIV in the African Cohort Study from 2013 through 2020, causes of death were ascertained in 54% of participants.
NigeriaVIH/sidaobservé 2013 through 2020publié 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 6 observations
70,6 %Of the 17 health facilities assessed in Abuja, Nigeria between February and May 2017, 12 (70.6%) provided nutritional support for people living with HIV/AIDS.
NigeriaVIH/sidaobservé February and May 2017publié 2021The Pan African medical journalPubMeddocument de 6 observations
69,4 %Among aging people living with HIV (PLWH) in Ibadan, Nigeria, the prevalence of any multimorbidity was 69.4%.
NigeriaVIH/sidaobservé 2018publié 2020AIDS research and human retrovirusesPubMeddocument de 3 observations
220 /μLIn the pre-fee cohort, the median baseline CD4 count was 220/μL, compared to 222/μL in the post-fee cohort.
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 9 observations
18,3 %HIV positivity was found in 37 out of 202 (18.3%) tuberculosis patients in the North Central zone of Nigeria.
Nigeriatuberculose · VIH/sidapublié 2019Journal of epidemiology and global healthPubMeddocument de 7 observations
8,05 scoreThe mean OHIP-14 score among HIV-positive patients in Nigeria was 8.05 with a standard deviation of 9.54.
NigeriaVIH/sidapublié 2021African health sciencesPubMeddocument de 5 observations
5,61 aORBeing a woman or girl on the move living with HIV was associated with experiencing more gender-based violence since COVID-19 started (adjusted odds ratio 5.61, 95% CI 3.01 to 10.47).
NigeriaVIH/sidapublié 2023BMJ global healthPubMeddocument de 5 observations
30 %Among 219 men who have sex with men (MSM) in Nigeria enrolled in the TRUST-PrEP study, only 66/219 (30%) had at least one record of protective serum tenofovir concentration (≥ 4.2 ng/mL).
NigeriaVIH/sidaobservé April 2018 to May 2019publié 2023PloS onePubMeddocument de 5 observations
0 %HIV positivity rate at the immunization clinic was 0%.
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 16 observations
25,4 %More females (25.4%) compared to males (20.8%) among adolescents and young adults (AYA) in Nigeria had ever tested for HIV.
NigeriaVIH/sidaobservé 2017publié 2020PloS onePubMeddocument de 4 observations
94,1 %Of the 17 health facilities assessed in Abuja, Nigeria between February and May 2017, 16 (94.1%) had well-established referral services for people living with HIV/AIDS.
NigeriaVIH/sidaobservé February and May 2017publié 2021The Pan African medical journalPubMeddocument de 6 observations
95,4 %Viral suppression rate among adults enrolled in differentiated service delivery models was 95.4% compared to 91.8% among those in standard care, with a p-value less than 0.01.
NigeriaVIH/sidapublié 2021Journal of the International AIDS SocietyPubMeddocument de 6 observations
52,5 %Non-adherence to antiretroviral therapy was reported in 456 participants (52.5%).
NigeriaVIH/sidapublié 2026BMC public healthPubMeddocument de 8 observations
1,5 aORAdolescents and young adults in the 'consent and proximity' class were more likely to report transactional sex (adjusted odds ratio 1.50, 95% confidence interval 1.23–1.84).
NigeriaVIH/sidaobservé 2018publié 2024PloS onePubMeddocument de 15 observations
274 casesAmong 16,727 female sex workers on antiretroviral therapy in Nigeria between 1 January 2016 and 31 August 2022, 274 (2%) had stopped ART by 31 August 2022.
NigeriaVIH/sidaobservé 2016-01-01 to 2022-08-31publié 2026BMC women's healthPubMeddocument de 11 observations
0,5 %The prevalence of HCV infection was 0.5% among HIV-naïve children in Lagos.
Nigeriahépatite C · VIH/sidapublié 2020PloS onePubMeddocument de 4 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.